News & Updates

Several factors, including male sex and reported cough, influence the decisions by clinicians to initiate tuberculosis (TB) treatment among individuals who receive a negative result on an initial bacteriological test for TB, reports a study.

Patients who had been infected with COVID-19 continue to experience symptoms at medium-term follow-up, showing greater high-sensitivity C-reactive protein (hsCRP) than controls, results of a study have shown.

Individuals with inflammatory bowel disease (IBD) appear to be at greater risk of developing chronic obstructive pulmonary disease (COPD) and asthma, suggests a study.

A remotely delivered structured weight management programme appears effective and safe in reducing symptoms that matter most among individuals with long COVID (LC) and overweight, findings from the wait-list-controlled open-label ReDIRECT trial suggest.

The prespecified final analysis of the phase III CHOICE-01 trial of toripalimab in combination with chemotherapy shows significant improvement in overall survival (OS) in treatment-naïve patients with advanced non-small-cell lung cancer (NSCLC) without EGFR/ALK driver mutations.